» Articles » PMID: 27017240

A Systematic Review of Decision Aids for Patients Making a Decision About Treatment for Early Breast Cancer

Overview
Journal Breast
Publisher Elsevier
Specialties Endocrinology
Oncology
Date 2016 Mar 28
PMID 27017240
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Several complex treatment decisions may be offered to women with early stage breast cancer, about a range of treatments from different modalities including surgery, radiotherapy, and endocrine and chemotherapy. Decision aids can facilitate shared decision-making and improve decision-related outcomes. We aimed to systematically identify, describe and appraise the literature on treatment decision aids for women with early breast cancer, synthesise the data and identify breast cancer decisions that lack a decision aid. A prospectively developed search strategy was applied to MEDLINE, the Cochrane databases, EMBASE, PsycINFO, Web of Science and abstract databases from major conferences. Data were extracted into a pre-piloted form. Quality and risk of bias were measured using Qualsyst criteria. Results were synthesised into narrative format. Thirty-three eligible articles were identified, evaluating 23 individual treatment decision aids, comprising 13 randomised controlled trial reports, seven non-randomised comparative studies, eight single-arm pre-post studies and five cross-sectional studies. The decisions addressed by these decision aids were: breast conserving surgery versus mastectomy (+/- reconstruction); use of chemotherapy and/or endocrine therapy; radiotherapy; and fertility preservation. Outcome measures were heterogeneous, precluding meta-analysis. Decisional conflict decreased, and knowledge and satisfaction increased, without any change in anxiety or depression, in most studies. No studies were identified that evaluated decision aids for neoadjuvant systemic therapy, or contralateral prophylactic mastectomy. Decision aids are available and improved decision-related outcomes for many breast cancer treatment decisions including surgery, radiotherapy, and endocrine and chemotherapy. Decision aids for neoadjuvant systemic therapy and contralateral prophylactic mastectomy could not be found, and may be warranted.

Citing Articles

Workflow analysis of breast cancer treatment decision-making: challenges and opportunities for informatics to support patient-centered cancer care.

Salwei M, Reale C JAMIA Open. 2024; 7(2):ooae053.

PMID: 38911330 PMC: 11192055. DOI: 10.1093/jamiaopen/ooae053.


Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.

Kautz-Freimuth S, Redaelli M, Shukri A, Kentenich H, Simic D, Mildenberger V BMC Med Inform Decis Mak. 2023; 23(1):223.

PMID: 37845719 PMC: 10580583. DOI: 10.1186/s12911-023-02327-9.


Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial.

Zisman-Ilani Y, Thompson K, Siegel L, MacKenzie T, Crate D, Korzenik J Aliment Pharmacol Ther. 2022; 57(2):205-214.

PMID: 36377259 PMC: 9790033. DOI: 10.1111/apt.17286.


A Systematic Review of Decision Aids in Hematologic Malignancies: What Are Currently Available and What Are We Missing?.

Zhao J, Abdallah M, Sanapala C, Watson E, LoCastro M, Castillo D Oncologist. 2022; 28(2):105-115.

PMID: 36342114 PMC: 9907042. DOI: 10.1093/oncolo/oyac231.


The role of tumor phenotype in the surgical treatment of early-stage breast cancer.

Rooney M, Thomas S, Taskindoust M, Greenup R, Rosenberger L, Hwang E Am J Surg. 2022; 225(1):84-92.

PMID: 36180300 PMC: 9912362. DOI: 10.1016/j.amjsurg.2022.09.029.